The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Aug. 12, 2015
Applicant:

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Yizhou Dong, Dublin, OH (US);

Joseph R. Dorkin, Somerville, MA (US);

Robert S. Langer, Newton, MA (US);

Daniel Griffith Anderson, Framingham, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 9/127 (2006.01); C08G 69/48 (2006.01); C08G 69/50 (2006.01); A61K 47/48 (2006.01); C08G 73/00 (2006.01); C08L 79/00 (2006.01); A61K 47/60 (2017.01); A61K 47/69 (2017.01); A61K 47/54 (2017.01); A61K 47/59 (2017.01); A61K 48/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 47/48207 (2013.01); A61K 9/1273 (2013.01); A61K 38/1816 (2013.01); A61K 47/544 (2017.08); A61K 47/554 (2017.08); A61K 47/595 (2017.08); A61K 47/60 (2017.08); A61K 47/6915 (2017.08); A61K 47/6935 (2017.08); A61K 48/00 (2013.01); C08G 69/48 (2013.01); C08G 69/50 (2013.01); C08G 73/00 (2013.01); C08L 79/00 (2013.01); C12N 15/1137 (2013.01); A61K 48/0041 (2013.01); C12N 2310/14 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present disclosure provides brush-poly(glycoamidoamine)-lipids (PGALs) (e.g., polymers of any one of Formulae (I)-(IV)) and methods of preparing the PGALs. A described PGAL may include poly(glycoamidoamine)-derived moieties (e.g., such as which may assist the PGAL and/or a complex of the PGAL and an agent to pass through cell membranes or be taken up by cells. Also provided are compositions including a described PGAL and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that include or involve the PGALs or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing in a subject a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, musculoskeletal diseases, genitourinary diseases, and metabolic disorders


Find Patent Forward Citations

Loading…